The study, led by Elio Rossi of the Regional Center for Integrative Medicine in Florence and published in the journal Supportive Care in Cancer, surveyed 176 oncologists, nurses, psycho-oncologists and other professionals working in oncology departments across the Tuscan Regional Health Service, one of the few public health systems in Europe that has formally embedded complementary and integrative medicine (CIM) into its cancer care network. The results offer a rare quantitative window into how the medical workforce on the front lines of cancer treatment actually perceives therapies — acupuncture, traditional Chinese medicine, homeopathy, nutritional counseling and more — that have long existed at the contested boundary between evidence-based oncology and alternative practice.

The survey instrument itself was carefully constructed. The Tuscan Regional Working Group “Integration of Complementary Medicine in the Regional Oncology Network” approved a 15-item questionnaire comprising 14 multiple-choice questions and a single open-ended question, allowing respondents both to quantify their views and to add free-text nuance. The survey was administered anonymously via Google Forms beginning in November 2024, with data collection closing in December 2024. The anonymous, digital-first design was intended to minimize social desirability bias — the tendency of professionals to give answers they believe their institutions expect — and the internal review board and the heads of the oncology departments of the Tuscan Oncology Network approved the protocol in July 2024.

The composition of the respondent pool lends the findings particular weight. Medical oncologists made up the largest single group at 39.2 percent, followed closely by nurses at 33 percent, with psycho-oncologists accounting for 4.5 percent and the remainder drawn from other professional categories working within cancer units. This distribution matters because these are precisely the clinicians who manage the daily reality of cancer treatment — the chemotherapy side effects, the pain, the anxiety, the sleep disruption — that integrative interventions claim to alleviate. Their assessments are not abstract opinion; they are grounded in direct observation of patients navigating both conventional anticancer therapy and optional CIM services.

When asked to evaluate the impact of integrative oncology services on cancer patients, the respondents delivered a verdict that was broadly positive, though far from unanimous. Just under a third — 32.4 percent — rated the services as useful, and 29.5 percent went further, judging them very useful. A further 23.3 percent described the impact as fair. On the skeptical side, 11.4 percent rated the impact as poor and 3.4 percent called it irrelevant. Taken together, more than 61 percent of professionals embedded in a conventional oncology environment judged publicly delivered integrative services as useful or very useful — a striking level of internal endorsement for a field that has historically faced deep institutional skepticism.

Referral behavior told a more layered story. Asked how frequently they recommend that patients visit the public integrative oncology clinics, 29 percent of respondents said “sometimes,” 22.2 percent said “rarely,” 15.9 percent “fairly often,” 15.3 percent “often,” 9.1 percent “very often,” and 8.5 percent said they never recommend them. The pattern suggests that while outright rejection of integrative services is a minority position, enthusiasm is tempered: most professionals refer selectively rather than systematically. Among the oncologists specifically, 47.7 percent reported recommending complementary and integrative medicine to their cancer patients — meaning that, within this network, recommending CIM is close to a coin-flip proposition among the very physicians prescribing chemotherapy, immunotherapy and radiotherapy.

What clinicians recommend is as revealing as how often they do so. Acupuncture dominated the list, cited by 51 percent of respondents as their most frequently recommended intervention, followed by nutritional counseling at 27 percent and generic integrative medicine consultations at 11 percent. Techniques drawn from traditional Chinese medicine, energy-based movement exercises, homeopathy and other modalities trailed behind. This hierarchy is consistent with the current state of clinical evidence: acupuncture has accumulated a relatively robust evidence base for chemotherapy-induced nausea, certain pain syndromes and, in some trials, aromatase inhibitor–related arthralgia in breast cancer, while nutritional counseling sits comfortably within mainstream supportive care. Homeopathy’s position on the list, despite its more contested scientific standing, reflects both its cultural entrenchment in Italy and the fact that Tuscan public clinics have long offered it under regulated conditions.

The Tuscan program itself is an institutional experiment unlike most. Beginning with regional resolutions in 2015 and 2016, the Region of Tuscany formally directed its local health authorities and university hospitals to integrate complementary medicine services into the oncological network of the Tuscan Tumor Institute, creating a regional referral center and a mapped network of integrative oncology outpatient clinics. The model rests on a specific architecture: CIM practitioners work alongside — not instead of — conventional oncology teams, interventions are positioned strictly as complementary to, never as substitutes for, standard anticancer treatment, and a regional working group coordinates training, clinical protocols and quality control. Prior work by the same group, published in 2023, described the operational process of building this integration within the public health system, and the new survey represents the first systematic effort to measure how the professionals inside that system judge the results.

The findings arrive amid a rapidly expanding international literature on clinician attitudes toward complementary medicine in oncology. Recent surveys from Germany, France, China, Iran, Tunisia and multinational cohorts have documented a consistent paradox: use of complementary therapies among cancer patients is high — systematic reviews suggest prevalence rates ranging from roughly a quarter to more than half of patients depending on the population — yet many clinicians feel underinformed about the evidence, undertrained in the modalities, and uncertain about safety issues such as herb–drug interactions. Studies have also documented the darker edge of unregulated use, including patients who refuse or delay conventional treatment in favor of alternatives, a pattern associated with worse outcomes. The Tuscan model is explicitly designed to counter this risk by bringing CIM inside the regulated perimeter of the public system, where interactions can be monitored and patients can be steered away from dangerous substitutions.

The authors are candid about both the promise and the limits of their results. They conclude that the integration of complementary and integrative medicine into oncology appears feasible, and they argue that shared clinical practice and open dialogue between conventional oncologists and CIM practitioners may reduce the mutual prejudices and institutional barriers that have historically kept the two worlds apart — ultimately benefiting patients. At the same time, they emphasize that further studies are warranted to better assess the clinical impact and generalizability of the approach. A cross-sectional survey of professionals in a single Italian region captures perceptions, not hard clinical endpoints: it can establish that the workforce finds the services acceptable and useful, but it cannot, by itself, prove that acupuncture or any other intervention improves survival, tumor response or even patient-reported quality of life at the population level. Nor can it fully rule out selection effects — professionals who chose to respond may differ systematically from those who did not.

Even so, the study lands at a moment of genuine momentum for integrative oncology internationally. Major cancer centers in North America and Europe have steadily expanded supportive and integrative oncology services, and professional societies have issued consensus definitions framing the field as the evidence-based use of complementary therapies alongside conventional treatment. The Italian data add a distinctive dimension to this conversation: evidence that a fully public, region-wide implementation — not a boutique program at a wealthy academic center — can achieve meaningful buy-in from the oncologists and nurses who must make it work in practice.

For patients and clinicians watching this debate unfold, the Tuscan experience suggests a pragmatic middle path. Rather than the sterile binary of uncritical embrace versus blanket dismissal, the model treats integrative oncology as a matter of clinical governance: which interventions, delivered by whom, under what oversight, for which symptoms, and with what monitoring. The survey’s numbers — broad but measured endorsement, selective referral patterns, and a clear preference for the best-evidenced modalities like acupuncture and nutritional support — read less like a manifesto for alternative medicine and more like the cautious verdict of working clinicians judging a service by its usefulness at the bedside. Whether that verdict translates into measurable improvements in patient outcomes will be the question that determines whether Tuscany’s experiment becomes a template or a cautionary tale — and the authors have made clear that the studies needed to answer it are the necessary next step.

Over the past decade, global policy initiatives have made significant strides in facilitating this integration. The World Health Organization’s Traditional Medicine Strategies (2014–2023 and the forthcoming 2025–2034) provide a strategic blueprint urging member states to formulate national policies that ensure the safe, effective, and equitable utilization of T&CM. These initiatives do not merely advocate coexistence; they promote systematic incorporation of traditional modalities into mainstream health systems to bolster healthcare accessibility, resilience, and cultural relevance. Countries such as China, India, South Korea, and Brazil stand at the forefront of these policy advancements, having developed comprehensive legal frameworks to validate and regulate traditional medicines alongside biomedicine.

In China, the 2017 Traditional Chinese Medicine Law represents a landmark enactment that integrates TCM deeply into the national healthcare infrastructure. This law mandates the inclusion of TCM services in over 90% of hospitals, effectively institutionalizing traditional practices within the biomedical model. India has taken parallel steps through the establishment of the Ministry of AYUSH, an agency dedicated to Ayurveda, Yoga, Unani, Siddha, Sowa-Rigpa, and Homeopathy, which promotes the co-location of traditional and modern medicine practitioners under one roof in public health facilities. South Korea’s dual licensing system uniquely formalizes the credentials of both Korean Medicine and biomedical providers, encouraging collaborative treatment approaches. Meanwhile, Brazil’s National Policy on Integrative and Complementary Practices (PNPIC) has incorporated 29 traditional healing approaches into the public health system (SUS), reflecting an expansive view of healthcare that embraces cultural pluralism and holistic care.

Successful integration relies not only on policy but also on robust regulatory and institutional structures that uphold safety, quality, and efficacy. Diverse regulatory agencies now oversee critical facets such as practitioner licensing, pharmacovigilance, quality assurance, and research oversight. India’s National Commission for Indian System of Medicine formulates standards for education and licensure, ensuring practitioner competency and accountability. In China, the National Medical Products Administration regulates the quality and safety of TCM products, introducing pharmacological scrutiny more typical of modern pharmaceutical oversight. European nations like Germany include naturopathy within their public health insurance schemes, reflecting a regulatory acceptance of complementary therapies, while Australia’s Therapeutic Goods Administration enforces stringent regulations on complementary medicines to guarantee consumer protection. However, these systemic frameworks are not universally consistent, with significant variations in regulation, enforcement, and integration levels persisting globally.

Clinical integration models represent the practical implementation of these strategies in healthcare settings. Four primary models illustrate varying degrees of collaboration. The co-location model physically situates T&CM practitioners within conventional facilities, promoting daily interaction and multidisciplinary care—as exemplified by India’s AYUSH centers or hospitals in South Korea. Referral-based models allow biomedical providers to direct patients to external traditional therapy providers, a common practice in Germany and Australia, reflecting a more segmented integration. Fully integrated services see T&CM and biomedical practitioners jointly developing treatment plans, a sophisticated approach evident in Chinese TCM hospitals and Japanese Kampo systems. Lastly, the parallel model sees patients independently accessing both medical systems without formal coordination, prevalent in the United States with widespread complementary therapy usage. Each model balances cultural expectations, resource availability, and systemic infrastructure, demonstrating the adaptability required in global health contexts.

Scientific validation and evidence generation remain paramount to bridging the epistemological divide between traditional knowledge and conventional medicine. Growing research substantiates the efficacy of multiple T&CM modalities in addressing chronic pain, stress, metabolic syndromes, and immune dysfunction. Bioactive compounds such as Ashwagandha and Turmeric from Ayurveda have demonstrated anti-inflammatory and immunomodulatory effects in numerous clinical and preclinical studies. Acupuncture’s analgesic efficacy is increasingly validated through neurophysiological and clinical trials, while mind-body therapies like Yoga show promising benefits for mental health and psychosomatic conditions. Major research institutions including India’s Central Council for Research in Ayurvedic Sciences and the U.S. National Center for Complementary and Integrative Health (NCCIH) spearhead methodologically rigorous investigations to cement the scientific foundations of traditional treatments.

The tangible impact of integrative medicine is evident in improved patient outcomes encompassing symptom management, enhanced quality of life, and better adherence to treatment regimens. Interprofessional collaboration fostered under integrative models not only enhances therapeutic efficacy but also contributes to a reduction in healthcare expenditures by lowering hospitalization rates and decreasing reliance on pharmaceuticals. Notably, systems in China and Brazil have advanced healthcare equity by expanding access to culturally congruent care for marginalized and indigenous communities, thereby addressing social determinants of health through inclusive medical approaches.

Despite these promising developments, integration faces numerous challenges. Foremost is the lack of large-scale, rigorous scientific validation covering the diverse range of T&CM modalities, limiting full acceptance within the biomedical community. This evidentiary gap stimulates resistance among medical professionals concerned about treatment safety and efficacy. Additionally, substantial disparities remain in practitioner education, standardization, and regulatory frameworks across different countries, complicating international harmonization efforts. Ethical considerations also arise around the commercialization of indigenous knowledge and intellectual property rights, raising questions about benefit-sharing and cultural preservation. Furthermore, funding and research support remain inadequate in proportion to the growing public demand and policy focus, hampering expansive translational research and clinical trials.

Addressing these barriers demands coordinated, multidisciplinary initiatives aimed at generating rigorous evidence, harmonizing regulations, and fostering interdisciplinary education. Ethical frameworks must safeguard the rights and heritage of indigenous communities, ensuring equitable inclusion in intellectual and economic gains derived from traditional knowledge. International collaboration protocols and data-sharing arrangements could accelerate the global integration agenda, standardizing education curricula and clinical protocols to prepare future health practitioners for integrative care delivery. This systemic effort is vital for the sustainable incorporation of traditional medicine as a complement, not opposition, to modern biomedical paradigms.

Looking toward the future, the integration of traditional and modern medicine promises to revolutionize healthcare delivery worldwide. This convergence offers a more inclusive, patient-centered approach deeply attuned to cultural identities and holistic well-being. Countries pioneering this integration serve as valuable models for global replication, demonstrating that evidence-based policies, robust regulatory environments, and adaptable clinical models can coexist and thrive. International cooperation, standardized education methodologies, and ethically grounded practices will be instrumental in unlocking the full potential of integrative medicine. Ultimately, this synthesis heralds a new era in healthcare—one that respects ancient healing wisdom while embracing scientific innovation to meet the complex health challenges of the 21st century.

Subject of Research: Integration of Traditional and Modern Medicine in Global Healthcare Systems
Article Title: Global Integration of Traditional and Modern Medicine: Policy Developments, Regulatory Frameworks, and Clinical Integration Model
News Publication Date: 4-Sep-2025
Web References: http://dx.doi.org/10.14218/FIM.2025.00033
Keywords: Alternative Medicine, Traditional Chinese Medicine, Ayurveda, Integrative Healthcare, Complementary and Alternative Medicine, Regulatory Frameworks, Clinical Integration, Health Policy

The design of the study was meticulously crafted as a randomized controlled trial, one of the most robust methodologies in clinical research aimed at evaluating treatment efficacy. The primary objective was to ascertain how warm saltwater baths and warm water baths correlate with improvements in critical health indicators among rheumatoid arthritis patients. The controlled nature of the study ensured that results were not skewed by external variables, thus reinforcing the validity of the findings.

Participants were selected based on specific inclusion criteria that adhered strictly to the guidelines set for rheumatoid arthritis. This included adults diagnosed with the condition who were experiencing joint pain, stiffness, and other associated symptoms. By focusing on a homogenous group, researchers ensured that the conclusions drawn would be more reliable and could be generalized to a broader population of rheumatoid arthritis sufferers.

As participants engaged in various bathing protocols, both in saltwater and freshwater environments, consistent assessments were made to monitor pain levels, fatigue, and sleep quality. These parameters were quantified using validated scales, allowing for objective measures of changes over the study period. Each participant received a thorough evaluation before, during, and after the bathing interventions to track improvements or any potential side effects.

Pain management is critical for improving the quality of life in rheumatoid arthritis patients, and the research highlighted significant advancements in pain relief for those undergoing warm baths. Warm water has been known for ages to have analgesic properties due to its ability to enhance blood circulation and promote tissue relaxation. Clinical evidence gathered from the study supports the notion that regular exposure to elevated water temperatures could lead to tangible pain relief, thereby improving overall patient satisfaction.

Moreover, fatigue is one of the lesser-discussed yet highly impactful components of rheumatoid arthritis. The study observed that participants who soaked in warm waters reported noticeably lower fatigue levels. The psychological benefits in conjunction with physiological responses would suggest that such bathing routines might not only alleviate physical symptoms but also contribute to enhanced emotional well-being.

Sleep quality, another critical area of concern in chronic pain patients, was similarly assessed. The results indicated that individuals who engaged in warm water baths experienced improvements in their sleep patterns. Sleep disruptions are common in patients with rheumatoid arthritis, and by utilizing hydrotherapy, there stands potential for non-pharmacological interventions to facilitate better rest. This aspect of the study underlines the far-reaching benefits of holistic approaches in medical treatment strategies.

Functional capacity was another vital parameter analyzed during the study. Researchers utilized various functional assessment tools to measure the range of motion, grip strength, and overall physical capability of participants. The findings revealed that consistent bathing in warm water—especially if combined with salt—could markedly enhance functional abilities, enabling patients to engage in daily activities with less discomfort.

As the medical community seeks to diversify treatment modalities for rheumatoid arthritis, this study fills a significant gap by highlighting an underutilized but effective therapy. Traditional treatments often focus on pharmacological solutions that may accompany unwanted side effects. Given the emerging trends in patient-centered care, incorporating hydrotherapy could provide a more comprehensive approach to managing this chronic disease.

The implications of these findings could foster a shift in how healthcare providers recommend holistic management options to patients. While medications remain a cornerstone of treatment, integrating non-invasive methods such as warm water baths could empower patients, promoting self-management practices that lead to better health outcomes.

Despite the promising nature of the findings, researchers advocate for further investigations to reinforce and expand on their conclusions. As this knowledge evolves, it would be prudent to explore the long-term effects of regular hydrotherapy and to identify optimal bathing practices that yield the best results for various patient demographics.

In conclusion, the research conducted offers essential insights into the potential of warm saltwater and warm water baths as viable adjunct therapies in managing rheumatoid arthritis. The positive outcomes regarding pain reduction, fatigue alleviation, sleep quality improvement, and enhanced functional capacity are significant and suggest that hydrotherapy could play a crucial role in modern rheumatological treatments. Broadening the scope of therapeutic options ultimately enriches the quality of care delivered to individuals grappling with difficult autoimmune challenges.

As the scientific community embraces these findings, it would not be surprising to see a gradual integration of hydrotherapy into standardized treatment protocols. The call for comprehensive, patient-oriented care is growing louder, and studies like this underscore the importance of bridging traditional medicine with alternative therapeutic practices. For patients wishfully navigating the challenges of rheumatoid arthritis, the journey towards relief may find a promising ally in the soothing embrace of warm waters.

Subject of Research: The effect of warm saltwater and warm water baths on pain, fatigue, sleep quality, and functional capacity in patients with rheumatoid arthritis.

Article Title: The effect of warm saltwater and warm water baths on pain, fatigue, sleep quality, and functional capacity in patients with rheumatoid arthritis: a randomized controlled study.

Article References:

Aktaş, O., Dönmez, A.A., Kapucu, S. et al. The effect of warm saltwater and warm water baths on pain, fatigue, sleep quality, and functional capacity in patients with rheumatoid arthritis: a randomized controlled study^✰.
BMC Complement Med Ther 25, 302 (2025). https://doi.org/10.1186/s12906-025-05050-2

Image Credits: AI Generated

DOI: 10.1186/s12906-025-05050-2

Keywords: Rheumatoid arthritis, warm saltwater baths, warm water baths, pain relief, fatigue, sleep quality, functional capacity, hydrotherapy, randomized controlled study.